SAN FRANCISCO, May 24, 2022 The global antimicrobial additives market size is expected to reach USD 4.3 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to expand at a CAGR of 5.6% from 2022 to 2030.
LOS ANGELES, May 24, 2022 /PRNewswire/ -- Limitless X Inc., a creative and empowering lifestyle agency that has launched industry-leading products in the Dietary Supplements, Beauty and Skincare and CBD sectors, announced that combat sports legends Floyd Mayweather Jr. and Anderson Silva represented both Limitless X and its SMILZ CBD brand at the Abu Dhabi Unity fight card held on May 21, 2022.
NEW YORK , May 23, 2022 Technavio categorizes the drugs of abuse testing market as a part of the global life science tools and services market. The drugs of abuse testing market research report provides valuable insights on the post-COVID-19 impact on the market, which will help companies evaluate their business approaches.
SILVER SPRING, Md., May 19, 2022 Today, the U.S. Food and Drug Administration announced the availability of a draft guidance aimed at increasing the amount of safety information the agency has about the dietary supplement marketplace by providing the industry an opportunity to submit late new dietary ingredient notifications.
REDDING, Calif. Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5171. Pharmaceutical contract development and manufacturing organization offers various services based on a contract to small or large pharmaceutical companies.
Bamboo Rose's Product Lifecycle Management and Sourcing applications will help the specialty retailer and wellness lifestyle company to digitize collaboration and improve data accuracy, standardization, and reusability in the creation of private brand supplement products BOSTON, May 17, 2022 /PRNewswire/ -- Bamboo Rose, the Boston-based multi-enterprise product and supply chain platform, is exc...
NEW YORK, May 12, 2022 Due to the increasing elderly population, growing demand for medicines, rising investment in healthcare, and the constant introduction of new products, the global biologics CDMO market was valued at $13,173.7 million in 2021. A share of 50% in the biologics CDMO market was held by drug substances in 2021, and this trend is expected to continue in the years to come.
- Relentless pursuit for improving the prognosis and survival rates spurs demand for radiotherapy; growing need for combining surgery with radiotherapy and chemotherapy boosting outcomes. - Pharmaceutical companies and cancer institute's collaborating for growing research spending on clinical trials for targeted therapies to expand growth frontiers for glioblastoma multiforme treatment market.
NEW YORK, May 11, 2022 The global NGS sample preparation market was worth around $1,598.8 million in 2021, and it is expected to reach $5,501.2 million by 2030, according to P&S Intlligrowing at a CAGR of 14.7% from 2021 to 2030, says P&S Intelligence. The pandemic has had a positive influence on the market.
The Ankylosing Spondylitis market size is anticipated to increase during the forecast period owing to the launch of several new products with novel mechanisms of action for Ankylosing Spondylitis treatment, including anti-IL17A, JAK inhibitors, and biologics.
News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.
PDF’s require Adobe® Reader® and will open in a new window.
Log In Required
Line of Credit Log In Required